The demographics of adverse outcomes in cystic fibrosis

Pediatr Pulmonol. 2019 Nov;54 Suppl 3(Suppl 3):S74-S83. doi: 10.1002/ppul.24434.

Abstract

Understanding variability in cystic fibrosis (CF) health outcomes requires an understanding of factors that go far beyond Cystic Fibrosis Transmembrane Receptor (CFTR) function caused by different gene mutations. Social and environmental factors that influence health have a significant influence on the trajectory of health in CF and in other chronic diseases. In this article, we review demographic factors associated with poorer health outcomes in CF, known and postulated biological mechanisms of these outcomes, and interventions that healthcare teams can implement that may reduce outcome disparities.

Keywords: cystic fibrosis; epidemiology; social dimensions of pulmonary medicine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cystic Fibrosis / epidemiology*
  • Cystic Fibrosis / ethnology
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis / mortality
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Demography
  • Ethnicity
  • Humans
  • Mutation
  • United States / epidemiology

Substances

  • Cystic Fibrosis Transmembrane Conductance Regulator